ANI PHARMACEUTICALS, INC (ANIP) Total liabilities 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) total liabilities at each fiscal year-end, per SEC filings.
$899.7MFY2025 · since FY2016: $153.2M → $899.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $899.7M | +5.1% |
| FY2024 | $855.9M | +91.6% |
| FY2023 | $446.8M | +6.0% |
| FY2022 | $421.5M | +2.1% |
| FY2021 | $412.9M | +55.5% |
| FY2020 | $265.5M | +8.8% |
| FY2019 | $244.0M | +4.6% |
| FY2018 | $233.3M | -1.7% |
| FY2017 | $237.4M | +54.9% |
| FY2016 | $153.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Gross marginANIP Operating incomeANIP Operating marginANIP Operating cash flowANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Shareholders’ equityANIP overview →